Search results for "PORIN"

showing 10 items of 260 documents

Azithromycin for the Treatment of Ciclosporin-Induced Gingival Hyperplasia

2016

medicine.medical_specialtyHistologybusiness.industryT cellmedicine.medical_treatmentDermatologyHematopoietic stem cell transplantationHyperplasiamedicine.diseaseAzithromycinCiclosporinGastroenterologyPathology and Forensic MedicineLymphomaGingivitismedicine.anatomical_structureInternal medicinemedicinemedicine.symptombusinessmedicine.drugActas Dermo-Sifiliográficas (English Edition)
researchProduct

Expression of Human Ubiquitous Aquaporins in Chorial Villus Samples

2011

Background/objectives: Aquaporins (AQPs) are a family of proteins (AQP0-12) ubiquitously expressed acting as cell membrane water channels. AQP 1/3/8/9 expression has been found in human placenta and fetal membranes; however, AQP4 is the only identified in first trimester fetal tissue samples. We aimed to determine AQP mRNA expression in first trimester of pregnancy and compare it to the expression in placenta at delivery. Material and Methods: 26 Chorionic villus (CV) samples and 5 placental samples were collected and analyzed by real time-PCR using Taqman assay (Applied Biosystems®) for human AQP1, 2, 3, 4, 5, 6, 7, 8, 9, 11 and 18S. Results: CV expressed high mRNA levels of AQP1, 3, 9 and…

medicine.medical_specialtyMessenger RNAPregnancyFetusAquaporinBiologymedicine.diseasemedicine.anatomical_structureEndocrinologyAquaporin 2Internal medicinePlacentaPediatrics Perinatology and Child HealthmedicineTaqManChorionic villiPediatric Research
researchProduct

2015

Several point mutations have been identified in human aquaporins, but their effects on the function of the respective aquaporins are mostly enigmatic. We analyzed the impact of the aquaporin 2 mutation V71M, which causes nephrogenic diabetes insipidus in humans, on aquaporin structure and activity, using the bacterial aquaglyceroporin GlpF as a model. Importantly, the sequence and structure around the V71M mutation is highly conserved between aquaporin 2 and GlpF. The V71M mutation neither impairs substrate flux nor oligomerization of the aquaglyceroporin. Therefore, the human aquaporin 2 mutant V71M is most likely active, but cellular trafficking is probably impaired.

medicine.medical_specialtyMutationurogenital systemPoint mutationMutantAquaporinBiologymedicine.disease_causeNephrogenic diabetes insipidusmedicine.diseaseGeneral Biochemistry Genetics and Molecular BiologyCell biologyEndocrinologyAquaporin 2Internal medicineArginine vasopressin receptor 2medicineProtein oligomerizationFEBS Open Bio
researchProduct

Aquaporin-4 distribution in control and stressed astrocytes in culture and in the cerebrospinal fluid of patients with traumatic brain injuries

2012

Distribution of aquaporin-4 (AQP4) was studied by western analysis and immunofluorescence in rat astrocytes exposed to either hypothermic (30 °C) or hyperosmolar (0.45 M sucrose) stress, and in the cerebrospinal fluid (CSF) of patients who suffered traumatic brain injury (TBI). CSF was obtained from 5 healthy subjects and from 20 patients suffering from severe TBI. CSF samples were taken at admission and on days 3 and 5-7. Here we report that, in response to both hypothermia and hyperosmolar stress, AQP4 was markedly reduced in cultured astrocytes. We also found that AQP4 significantly increased in patients with severe brain injury in respect to healthy subjects (P < 0.002). AQP4 in CSF rem…

medicine.medical_specialtyPathologyNeurologyTraumatic brain injuryaquaporin-4DermatologyImmunofluorescencecerebrospinal fluidCerebrospinal fluidStress PhysiologicalSettore BIO/10 - BiochimicamedicineAnimalsHumansDistribution (pharmacology)Settore BIO/06 - Anatomia Comparata E CitologiaRats WistarCells CulturedAquaporin 4medicine.diagnostic_testbusiness.industrytraumatic brain injuryCultured astrocyteGeneral MedicineHypothermiamedicine.diseaseRatsPsychiatry and Mental healthAquaporin 4AstrocytesBrain InjuriesAnesthesiasense organsNeurology (clinical)Neurosurgerymedicine.symptombusinessNeurological Sciences
researchProduct

The 2016 European Thyroid Association/European Group on Graves' Orbitopathy Guidelines for the Management of Graves' Orbitopathy

2015

Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease, though severe forms are rare. Management of GO is often suboptimal, largely because available treatments do not target pathogenic mech anisms of the disease. Treatment should rely on a thorough assessment of the activity and severity of GO and its impact on the patient's quality of life. Local measures (artificial tears, ointments and dark glasses) and control of risk factors for progression (smoking and thyroid dysfunction) are recommended for all patients. In mild GO, a watchful strategy is usually sufficient, but a 6-month course of selenium supplementation is effective in improving mild manifestations …

medicine.medical_specialtyPediatricsCyclosporine; Eyelid surgery; Glucocorticoids; Graves' orbitopathy; Orbital decompression; Orbital radiotherapy; Rituximab; Selenium; Squint surgeryEndocrinology Diabetes and Metabolismmedicine.medical_treatmentMedizin030209 endocrinology & metabolismDiseaseGuidelines03 medical and health sciencesGraves' orbitopathySeleniumEndocrinology0302 clinical medicineQuality of lifemedicineEyelid surgeryOrbital radiotherapyGlucocorticoidsbusiness.industryCumulative doseThyroideye diseasesSurgeryDiabetes and MetabolismOrbital decompressionArtificial tearsmedicine.anatomical_structureMethylprednisolone030221 ophthalmology & optometryCyclosporineRituximabSquint surgerybusinessRituximabWatchful waitingCyclosporine; Eyelid surgery; Glucocorticoids; Graves' orbitopathy; Orbital decompression; Orbital radiotherapy; Rituximab; Selenium; Squint surgery; Endocrinology Diabetes and Metabolismmedicine.drug
researchProduct

Optimizing ceftolozane-tazobactam dosage during continuous renal replacement therapy: additional insights

2019

medicine.medical_specialtyTazobactamLetterContinuous Renal Replacement Therapybusiness.industrymedicine.medical_treatmentCritical IllnessCEFTOLOZANE/TAZOBACTAMlcsh:Medical emergencies. Critical care. Intensive care. First aidlcsh:RC86-88.9Critical Care and Intensive Care MedicineCephalosporinsmedicineHumansRenal replacement therapyIntensive care medicinebusinessCritical Care
researchProduct

A randomized clinical trial of topical dexamethasone vs. cyclosporine treatment for oral lichen planus

2021

BACKGROUND Oral lichen planus (OLP) is a common, frequently symptomatic, immune-mediated disease. Various treatments have been used for symptomatic OLP, including corticosteroids and immunosuppressants administered topically or systemically. The aim of this study was to compare the effectiveness of topical dexamethasone vs. topical cyclosporine in treatment of symptomatic OLP. MATERIAL AND METHODS Thirty-two patients with biopsy-proven symptomatic OLP were randomly assigned to two therapeutic groups: dexamethasone 2mg/5ml or cyclosporine 100mg/ml, both administered topically in a swish and spit method three times a day for 4 weeks. The patients were followed up for a total of 6 months. Asse…

medicine.medical_specialtyTopical dexamethasoneAdministration TopicalGastroenterologyDexamethasonelaw.inventionRandomized controlled triallawInternal medicinemedicine3-d printingHumansGeneral DentistryDexamethasoneUNESCO:CIENCIAS MÉDICASbusiness.industryorthognathic surgerysplintsmedicine.diseaseDysphagiaTreatment periodDiscontinuationClinical trialOtorhinolaryngologydata accuracyCyclosporineSurgeryOral lichen planusmedicine.symptombusinessImmunosuppressive Agentsmedicine.drugLichen Planus Oral
researchProduct

Considerazioni su un caso di actinomicosi cervicale

2005

Actinomycosis is a bacterial infection due to Gram positive bacteria of Actinomyces genus. Actinomyces israelii is the most common in human infection.The authors described a case occurred in a 43 aged woman with a clinical presentation of a right submandibular indurative mass.After surgery, histological examination showed a granulomatous tissue with many actinomycetes. Patient was submitted to treatment with i.v penicillin. On the 11th day antibiotic therapy was replaced with ceftriaxone and teicoplanina. Patient did not present intercurrence during this period and presented improvement of the lesion.Actinomycosis is an uncommon disease. Establishment of the definite diagnosis requires a hi…

medicine.medical_specialtybiologymedicine.drug_classbusiness.industryGram-positive bacteriaCephalosporinlcsh:QR1-502General Medicinemedicine.diseaseActinomyces israeliibiology.organism_classificationlcsh:MicrobiologySurgeryPenicillinAntibiotic therapyLymphoadenopaty actinomycosis flogosysmedicineCeftriaxoneActinomycosisbusinessHistological examinationmedicine.drugMicrobiologia Medica
researchProduct

Nonsteroid Immunosuppressants in Endocrine Orbitopathy

2009

medicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismAziridinesEndocrine orbitopathyGeneral MedicineDermatologyGraves DiseaseEndocrinologyAzathioprineCyclosporineInternal MedicinemedicineHumansbusinessCyclophosphamideImmunosuppressive AgentsExperimental and Clinical Endocrinology &amp; Diabetes
researchProduct

Systemic therapies for Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: a SCORTEN-based systematic review and meta-analysis.

2020

Background The SCORTEN score is a specific predictor of mortality for patients with Stevens-Johnson syndrome (SJS)/toxic epidermal necrolysis (TEN). There is little evidence in support of the common immunomodulating therapies for SJS/TEN. Objectives To systematically assess the effectiveness of several therapies for SJS/TEN through the SCORTEN score. Methods Databases were searched for original studies on the use of SCORTEN. Six meta-analyses were carried out on patients with SJS/TEN who received supportive care only or in combination with immunomodulating drugs: corticosteroids, cyclosporine, etanercept, immunoglobulins or a combination of corticosteroids with immunoglobulins. A multivaria…

medicine.medical_specialtybusiness.industryStevens johnsonRetrospective cohort studyDermatologymedicine.diseaseToxic epidermal necrolysisEtanerceptstomatognathic diseases030207 dermatology & venereal diseases03 medical and health sciences0302 clinical medicineInfectious DiseasesAdrenal Cortex Hormones030220 oncology & carcinogenesisInternal medicineMeta-analysisStevens-Johnson SyndromeCyclosporineMedicineHumansbusinessmedicine.drugRetrospective StudiesJournal of the European Academy of Dermatology and Venereology : JEADVReferences
researchProduct